Voluntary Recall Information


Philips Respironics Sleep and Respiratory Care devices

Information for business customers

 

We are committed to partnering with you to support all affected patients.

 

As we continue to make progress on the remediation of CPAP, BiPAP and ventilator devices it is important that you are informed on the latest updates. We will continue to update our remediation progress page throughout the process.

 

Ventilation information

Lung icon

The remediation of the ventilator devices remains ongoing. Philips Respironics will communicate with Durable Medical Equipment providers (DMEs) as updates become available. Please visit our ventilation news and updates page for the latest information.

Sleep Therapy information

Sleep icon

We have first-generation DreamStation and DreamStation 2 devices available to ship and are asking customers and clinicians to help us to remind patients that they may need to take a specific action in the Patient Portal to receive their replacement device.


Some patients may have the option to choose a replacement device with Auto-adjusting CPAP settings if we have been unable to obtain their updated prescription settings. Learn more about Auto-adjusting CPAP options for your patients here.

DreamStation 2

Your patients may receive a DreamStation 2 as a replacement for their affected CPAP device.

The Philips Learning connection hosts educational modules that provide overviews of the DreamStation 2 and DreamStation 2 Advanced.

Latest updates

Explained: The voluntary Philips Respironics sleep and respiratory care devices recall*

 

* This is a voluntary recall notification in the US and field safety notice in other countries

Explained: The Philips Respironics Consent Decree

April 4, 2024

Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice

September 27, 2023

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.